TA
DXCM icon

Tamarack Advisers’s DexCom DXCM Stock Holding History

Tamarack Advisers’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-100,000
Closed -$9.33M – 8
2023
Q3 		$9.33M Buy
+100,000
New +$11.3M 6.04% 3

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Tamarack Advisers's DXCM Position: Q3 2023 in Review

Tamarack Advisers sold out of DexCom (DXCM) in Q3 2023, closing a stake of 16,000 shares — an estimated $1.8M sold.

Tamarack Advisers first reported a position in DXCM in Q1 2016 and held it in 3 quarters. The position peaked at $5.16M in Q2 2016. 902 funds tracked by Wall St. Rank hold DXCM as of Q3 2023.

  • Tamarack Advisers reported no remaining DexCom position as of Q3 2023 after selling out during the quarter.
  • Tamarack Advisers sold 16,000 DexCom shares in Q3 2023, an estimated $1.8M.
  • Tamarack Advisers first reported a position in DexCom in Q1 2016 and held it in 3 quarters.
  • Tamarack Advisers's DexCom position peaked at $5.16M in Q2 2016.
  • 902 funds tracked by Wall St. Rank held DexCom as of Q3 2023.

Based on Tamarack Advisers's 13F filing for Q3 2023, filed 16 Nov 2023.